A clinical preparation with wide-spectral antimicrobial effect against the bacteria of Staphylococcus aureus, Klebsiella pneumoniae and Acinetobacter baumannii with a content of bacteriophages

Abstract

A biological medicinal product with a defined composition (phage lysate with antistaphylococcal activity, phage lysate with antiacinetobacter activity and phage lysate with antiklebsiella activity), which can be applied in a stable dose (higher ≥ 1 × 10 PFU / ml) enabling the destruction of bacterial cells at the site of ongoing infection ( , , ). Its solution can also be used in the form of an aerosol (e.g. nasal spray) with effects not only in the nasal cavity, but also in the entire respiratory system.